Under the influence of LSD, the rats ran less and displayed less neuronal activity in their hippocampi.
Under the new measure, “the personal possession and therapeutic use of Entheogenic Plants by adults” with become “the city’s lowest law-enforcement priority.”
“Ketamine is helpful as a medicine, but there’s so much more to be gained by adding the psychotherapy component,” says Dr Reid Robison, Novamind’s chief medical officer.
Led by experienced natural products chemists, Psilera Bioscience is on a mission to create new, next-generation psychedelic medicines that can better serve patients’ needs.
Scientists at Medicinal Genomics have published a peer-reviewed, highly-contiguous reference genome for the psychedelic mushroom species Psilocybe cubensis.
Taking psilocybin can affect one’s emotional state when listening to music, according to new research presented earlier this month.
To address this, two British ambulance services are now participating in a new trial to investigate whether ketamine injections may be a more effective relief treatment for severe injury pain than the current treatment options available to Britain’s first responders.
Mydecine Innovations Group has announced its partnership with the renowned psychedelic science researcher Dr Matthew Johnson of Johns Hopkins University to carry the clinical trial.
Recruitment is now underway for a first-of-its-kind study investigating the potential of ketamine to fight gambling addiction.